| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.078 | 0.1 |